 |
PDBsum entry 5d0k
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Ligase
|
 |
|
Title:
|
 |
Structure of ube2d2:rnf165:ub complex
|
|
Structure:
|
 |
Ubiquitin-conjugating enzyme e2 d2. Chain: a, d, g, j. Synonym: ubiquitin carrier protein d2,ubiquitin-conjugating enzyme e2(17)kb 2,ubiquitin-conjugating enzyme e2-17 kda 2,ubiquitin-protein ligase d2,p53-regulated ubiquitin-conjugating enzyme 1. Engineered: yes. Mutation: yes. Ring finger protein 165. Chain: c, f, i, l.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: ube2d2, pubc1, ubc4, ubc5b, ubch4, ubch5b. Expressed in: escherichia coli. Expression_system_taxid: 562. Gene: rnf165. Gene: ubb. Expression_system_taxid: 562
|
|
Resolution:
|
 |
|
2.65Å
|
R-factor:
|
0.194
|
R-free:
|
0.238
|
|
|
Authors:
|
 |
J.D.Wright,C.L.Day,P.D.Mace
|
|
Key ref:
|
 |
J.D.Wright
et al.
(2016).
Secondary ubiquitin-RING docking enhances Arkadia and Ark2C E3 ligase activity.
Nat Struct Biol,
23,
45-52.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
03-Aug-15
|
Release date:
|
09-Dec-15
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P62837
(UB2D2_HUMAN) -
Ubiquitin-conjugating enzyme E2 D2 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
147 a.a.
148 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class 2:
|
 |
Chains A, D, G, J:
E.C.2.3.2.23
- E2 ubiquitin-conjugating enzyme.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [E2 ubiquitin-conjugating enzyme]-L-cysteine = [E1 ubiquitin-activating enzyme]-L-cysteine + S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L- cysteine
|
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
Chains A, D, G, J:
E.C.2.3.2.24
- (E3-independent) E2 ubiquitin-conjugating enzyme.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E1 ubiquitin-activating enzyme]-L-cysteine + N6- monoubiquitinyl-[acceptor protein]-L-lysine
|
 |
 |
 |
 |
 |
Enzyme class 4:
|
 |
Chains B, E, H, K:
E.C.?
|
|
 |
 |
 |
 |
 |
Enzyme class 5:
|
 |
Chains C, F, I, L:
E.C.2.3.2.27
- RING-type E3 ubiquitin transferase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N6- ubiquitinyl-[acceptor protein]-L-lysine
|
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nat Struct Biol
23:45-52
(2016)
|
|
PubMed id:
|
|
|
|
|
| |
|
Secondary ubiquitin-RING docking enhances Arkadia and Ark2C E3 ligase activity.
|
|
J.D.Wright,
P.D.Mace,
C.L.Day.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
RING-domain E3 ligases enhance transfer of ubiquitin to substrate proteins by
stabilizing the RING-bound thioester-linked E2∼ubiquitin conjugate in a
defined conformation that primes the active site for nucleophilic attack. Here
we report that the monomeric RING domains from the human E3 ligases Arkadia and
Ark2C bind directly to free ubiquitin with an affinity comparable to that of
other dedicated ubiquitin-binding domains. Further work showed that the Ark-like
RING domain and the noncovalently bound ubiquitin molecule coordinately
stabilize the E2-conjugated ubiquitin (donor ubiquitin) in the 'closed'
conformation. Our studies identify the RING domain of Arkadia as a
ubiquitin-binding domain and provide insight into a new ubiquitin-dependent
mechanism used by monomeric RING domains to activate ubiquitin transfer. This
study also suggests how substrates that have been monoubiquitinated could be
favored for further ubiquitination.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
| |